MARKET

ICLR

ICLR

ICON plc
NASDAQ
185.27
-0.16
-0.09%
After Hours: 185.45 +0.18 +0.10% 19:33 10/23 EDT
OPEN
184.25
PREV CLOSE
185.43
HIGH
185.57
LOW
179.89
VOLUME
1.02M
TURNOVER
--
52 WEEK HIGH
203.91
52 WEEK LOW
66.57
MARKET CAP
14.29B
P/E (TTM)
205.99
1D
5D
1M
3M
1Y
5Y
1D
Is ICON (ICLR) A Bargain Following Strong Bookings And Backlog?
Simply Wall St · 4h ago
How Strong Bookings At ICON (ICLR) Has Changed Its Investment Story
Simply Wall St · 1d ago
DaVita Inc. Stock Slips 6.2%, Underperforms Peers
Dow Jones · 3d ago
DaVita Inc. stock underperforms Tuesday when compared to competitors
MarketWatch · 3d ago
Analysts Offer Insights on Healthcare Companies: Sysmex (OtherSSMXF), Icon (ICLR) and Shattuck Labs (STTK)
TipRanks · 4d ago
ICON plc (ICLR) Executive Moves to Dismiss Securities Fraud Claims, Citing No Statements and Lack of Jurisdiction
TipRanks · 4d ago
Weekly Report: what happened at ICLR last week (1012-1016)?
Weekly Report · 5d ago
RBC Capital Keeps Their Buy Rating on Icon (ICLR)
TipRanks · 10/12 11:45
More
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.